Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB841, C1, SFB841, C1)
Deutsche Forschungsgemeinschaft (SFB877, A1)
Deutsche Forschungsgemeinschaft (Cluster of Excellence 'Precision Medicine in Chronic Inflammation')
Article History
Received: 31 December 2020
Accepted: 28 April 2021
First Online: 28 May 2021
Declarations
: Conflict of interest
: S.R.-J. is an inventor of patents owned by the CONARIS Research Institute, which develops the sgp130Fc protein together with Ferring Pharmaceuticals, and he has stock ownership in CONARIS. No conflicts of interest, financial or otherwise, are declared by E.G. and D.S.-A.